| ［1］ Choi YH, Yu AM. ABC tranceporters in multidrug resisitance and pharmacokinetics and strategies for drug development［J］. Curr Pharm Des, 2014, 20(5): 793-807.
［2］ Wang QP, Wang Y, Wang XD, et al. Survivin upregulates the expression of breast cancer resistance protein (BCRP) through attenuating the suppression of p53 on NF-κB expression in MCF-7/5FU cells［J］. Int J Biochem Cell Biol, 2013, 45 (9): 2036-2044.
［3］ Wheatley SP, Wang Y, Wang XD, et al. The functional repertoire of survivin′s tail［J］. Cell Cycle, 2015, 14(2): 261-268.
［4］ Zheng GH, Fu JR, Xu YH, et al. Screening and cloning of multidrug resistant genes in HL60/MDR cells［J］. Leuk Res, 2009, 33(8): 1120-1123.
［5］ Liu H, Luo Y, Li S, et al. Expression profiles of HA117 and its neighboring gene DPF3 in different colon segments of Hirschsprung′s disease［J］. Int J Clin Exp Pathol, 2014, 7(7): 3966-3974.
［6］ Guey B, Bodnar M, Manié SN, et al. Caspase1 autoproteolysis is differentially required for NLRP1b and NLRP3 inflammasome function［J］. Proc Natl Acad Sci USA, 2014, 111(48): 17254-17259.
［7］ Chu LH, Gangopadhyay A, Dorfleutner A, et al. An updated view on the structure and function of PYRIN domains［J］. Apoptosis, 2015, 20(2): 157-173.
［8］ Luqman S, Pezzuto JM. NFkappaB: a promising target for natural products in cancer chemoprevention［J］. Phytother Res, 2010, 24(7): 949-963.
［9］ Hitzler I, Sayi A, Kohler E, et al. Caspase-1 has both proinflammatory and regulatory properties in helicobacter infections, which are differentially mediated by its substrates IL-1beita and IL-18［J］. J Immunol, 2012, 188(8): 3594-3602.
［10］ Ola MS, Nawaz M, Ahsan H, et al. Role of Bcl-2 family proteins and caspases in the regulation of apoptosis［J］. Mol Cell Biochem, 2011, 351(1-2): 41-58.
［11］ Siddiqui WA, Ahad A, Ahsan H, et al. The mystery of BCL2 family: Bcl-2 proteins and apoptosis:an update［J］. Arch Toxicol, 2015, 89(3): 289-317.
［12］ Luanpitpong S, Chanvorachote P, Stehlik C, et al. Regulation of apoptosis Bcl-2 cysteine oxidation in human lung epithelial cells［J］. Mol Biol Cell, 2013, 24(6): 858-869.
［13］ Vervliet T, Decrock E, Molgó J, et al. Bcl-2 binds to and inhibits ryanodine receptors［J］. J Cell Sci, 2014, 127(Pt12): 2782-2792.
［14］ Zheng GH, Guo YX, Jin X, et al. Construction, screening and evaluation of a derivative recombinant adenovirus for the optimal siRNA targeting of a novel gene (HA117)［J］. Gene, 2011, 479(1-2): 10-15.
［15］ 段文娟， 金先庆， 徐酉华， 等. HA117编码蛋白、P-gp和bcl-2在儿童急性白血病中的表达及意义［J］. 中国小儿与血液肿瘤杂志， 2013， 18（5）： 201-205.
［16］ 孙艳辉. ATRA相关新基因HA117作用、机制及其临床意义研究［D］. 重庆：重庆医科大学， 2013.
［17］ Zhao LH, Jin X, Xu Y, et al. Functional study of the novel multidrug resistance gene HA117 and its comparison to multidrug resistance gene 1［J］. J Exp Clin Cancer Res, 2010, 29: 98.
［18］ Zhao LH, Sun YH, Li XQ, et al. Multidrug resistance strength of the novel multidrug resistance gene HA117: compared with MRP1［J］. Med Oncol, 2011, 28(4): 1188-1195.
［19］ Guo Y, Zheng G, Jin X, et al. HA117 gene increased the multidrug resistance of K562 cells in vitro: an investigation to the function of a novel gene related to drug resistance［J］. J Exp Clin Cancer Res, 2009, 28: 63.
［20］ 吴遐， 王俊和. HA117在成人急性白血病中的表达及意义［J］. 国际肿瘤学杂志， 2011， 38（8）： 636639.
［21］ 胡田田， 徐酉华， 沈亚莉， 等. 新基因HA117编码蛋白在儿童急性白血病中的表达及其临床意义［J］. 第三军医大学学报， 2012， 34（3）： 121125.
［22］ Zheng GH, Luo Q, Jin XQ, et al. Screening siRNAs targeting a novel gene (HA117) and the development of a derivative recombinant adenovirus delivery system［J］. Cancer Gene Ther, 2011, 18(9): 655662.
［23］ Duan WJ, Jin XQ, Xiu Y, et al. Expression of the novel alltrans retinoic acidrelated resistance gene HA117 in pediatric solid tumors［J］. J Pediatr Hematol Oncol, 2014, 36(1): 4550.
［24］ 李昆昆， 金先庆， 牟廷刚， 等. ATRA耐药基因HA117相关蛋白在四种恶性肿瘤的表达及临床意义［J］. 临床小儿外科杂志， 2011， 10（4）： 250253. |
